The document proposes an immunological model for access control to clinical data architecture (CDA) documents. It suggests treating CDA documents like immune system molecules that have a recognition end to identify targets and an effector end to determine the action. Similarly, an access lock pointer would pair with each CDA to act as the recognition end, while authentication mechanisms like dual key cryptography would act as the effector end to retrieve the selected CDA. The model aims to enable a universal access mechanism for shared healthcare records while respecting privacy.